These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1920364)

  • 1. Peptide to glycopeptide: glycosylated oligopeptide renin inhibitors with attenuated in vivo clearance properties.
    Fisher JF; Harrison AW; Bundy GL; Wilkinson KF; Rush BD; Ruwart MJ
    J Med Chem; 1991 Oct; 34(10):3140-3. PubMed ID: 1920364
    [No Abstract]   [Full Text] [Related]  

  • 2. Appraisal of a glycopeptide cloaking strategy for a therapeutic oligopeptide: glycopeptide analogs of the renin inhibitor ditekiren.
    Harrison AW; Fisher JF; Guido DM; Couch SJ; Lawson JA; Sutter DM; Williams MV; DeGraaf GL; Rogers JE; Pals DT
    Bioorg Med Chem; 1994 Dec; 2(12):1339-61. PubMed ID: 7788297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro/in vivo models for peptide oral absorption: comparison of Caco-2 cell permeability with rat intestinal absorption of renin inhibitory peptides.
    Conradi RA; Wilkinson KF; Rush BD; Hilgers AR; Ruwart MJ; Burton PS
    Pharm Res; 1993 Dec; 10(12):1790-2. PubMed ID: 8302767
    [No Abstract]   [Full Text] [Related]  

  • 4. Renin inhibitor: relationship between molecular structure and oral absorption.
    Hashimoto N; Fujioka T; Hayashi K; Odaguchi K; Toyoda T; Nakamura M; Hirano K
    Pharm Res; 1994 Oct; 11(10):1443-7. PubMed ID: 7855049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic elimination in the rat of ditekiren (U-71038), a renin inhibitor pseudohexapeptide.
    Adedoyin A; Perry PR; Wilkinson GR
    Drug Metab Dispos; 1993; 21(1):184-8. PubMed ID: 8095217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of physicochemical parameters important to the oral bioavailability of peptide-like compounds: implications for the synthesis of renin inhibitors.
    Hamilton HW; Steinbaugh BA; Stewart BH; Chan OH; Schmid HL; Schroeder R; Ryan MJ; Keiser J; Taylor MD; Blankley CJ
    J Med Chem; 1995 Apr; 38(9):1446-55. PubMed ID: 7739003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and discovery in the development of long-acting renin inhibitors.
    Veber DF; Payne LS; Williams PD; Perlow DS; Lundell GF; Gould NP; Siegl PK; Sweet CS; Freidinger RM
    Biochem Soc Trans; 1990 Dec; 18(6):1291-4. PubMed ID: 2088926
    [No Abstract]   [Full Text] [Related]  

  • 8. Disposition, metabolism, and excretion of U-71038, a novel renin inhibitor peptide, in the rat.
    Greenfield JC; Cook KJ; O'Leary IA
    Drug Metab Dispos; 1989; 17(5):518-25. PubMed ID: 2573495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of serine O-glycosylation on cis-trans proline isomerization.
    Pao YL; Wormarld MR; Dwek RA; Lellouch AC
    Biochem Biophys Res Commun; 1996 Feb; 219(1):157-62. PubMed ID: 8619800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate analogue renin inhibitors containing replacements of histidine in P2 or isosteres of the amide bond between P3 and P2 sites.
    Raddatz P; Jonczyk A; Schmitges CJ; Sombroek J
    Adv Exp Med Biol; 1991; 306():387-90. PubMed ID: 1812733
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the bile acid transporter in enhancing intestinal permeability to renin-inhibitory peptides.
    Kim DC; Harrison AW; Ruwart MJ; Wilkinson KF; Fisher JF; Hidalgo IJ; Borchardt RT
    J Drug Target; 1993; 1(4):347-59. PubMed ID: 8069578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and tissue distribution of the renin inhibitor N-(2-(R)-benzyl-3-tert-butyl-sulfonyl-propionyl)-His-ChacVal-n-butylami ne in marmosets.
    Cumin F; Schnell C; Richert P; Raschdorf F; Probst A; Schmid K; Wood JM; de Gasparo M
    Drug Metab Dispos; 1990; 18(6):831-5. PubMed ID: 1981524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin inhibitors. II. Synthesis and structure-activity relationships of N-terminus modified inhibitors containing a homostatine analogue.
    Atsuumi S; Nakano M; Koike Y; Tanaka S; Funabashi H; Matsuyama K; Nakano M; Sawasaki Y; Funabashi K; Morishima H
    Chem Pharm Bull (Tokyo); 1992 Dec; 40(12):3214-21. PubMed ID: 1294323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and dynamics of mucin-like glycopeptides. Examination of peptide chain expansion and peptide-carbohydrate interactions by stochastic dynamics simulations.
    Butenhof KJ; Gerken TA
    Biochemistry; 1993 Mar; 32(10):2650-63. PubMed ID: 8448122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of inhibitors of human renin with high oral bioavailability.
    Hoover DJ; Lefker BA; Rosati RL; Wester RT; Kleinman EF; Bindra JS; Holt WF; Murphy WR; Mangiapane ML; Hockel GM
    Adv Exp Med Biol; 1995; 362():167-80. PubMed ID: 8540316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational implications of asparagine-linked glycosylation.
    Imperiali B; Rickert KW
    Proc Natl Acad Sci U S A; 1995 Jan; 92(1):97-101. PubMed ID: 7816856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP-dependent transport of the linear renin-inhibiting peptide EMD 51921 by canalicular plasma membrane vesicles of rat liver: evidence of drug-stimulatable ATP-hydrolysis.
    Ziegler K; Kolac C; Ising W
    Biochim Biophys Acta; 1994 Dec; 1196(2):209-17. PubMed ID: 7841185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Water-soluble renin inhibitors: design of a subnanomolar inhibitor with a prolonged duration of action.
    Rosenberg SH; Woods KW; Sham HL; Kleinert HD; Martin DL; Stein H; Cohen J; Egan DA; Bopp B; Merits I
    J Med Chem; 1990 Jul; 33(7):1962-9. PubMed ID: 2194033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosylated enfuvirtide: a long-lasting glycopeptide with potent anti-HIV activity.
    Cheng S; Chang X; Wang Y; Gao GF; Shao Y; Ma L; Li X
    J Med Chem; 2015 Feb; 58(3):1372-9. PubMed ID: 25594223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro stability and intestinal absorption characteristics of hexapeptide endothelin receptor antagonists.
    Han HK; Stewart BH; Doherty AM; Cody WL; Amidon GL
    Life Sci; 1998; 63(18):1599-609. PubMed ID: 9806213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.